BRAINSWAY (Israel) Today

BRAINSWAY is trading at 1274.00 as of the 27th of September 2021, a 0.24 percent up since the beginning of the trading day. The stock's open price was 1271.0. Equity ratings for BRAINSWAY LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2021 and ending today, the 27th of September 2021. Click here to learn more.
Check how we calculate scores

BRAINSWAY Stock Profile

Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. BRAINSWAY operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 100 people. more on BRAINSWAY
BRAINSWAY LTD is not yet fully synchronised with the market data
The company reported the revenue of 26.21 M. Net Loss for the year was (4.68 M) with profit before overhead, payroll, taxes, and interest of 18.06 M.
BRAINSWAY LTD has accumulated about 55.87 M in cash with (1.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.73.
Roughly 17.0% of the company shares are held by company insiders
CEOChristopher Jako  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BRAINSWAY's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
BRAINSWAY LTD (BWAY) is traded on Tel Aviv Stock Exchange in Israel and employs 100 people. The company currently falls under 'Large-Cap' category with current market capitalization of 41.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BRAINSWAY's market, we take the total number of its shares issued and multiply it by BRAINSWAY's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BRAINSWAY LTD operates under Healthcare sector and is part of Medical Devices industry. The entity has 32.9 M outstanding shares. BRAINSWAY LTD has accumulated about 55.87 M in cash with (1.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.73.
Check BRAINSWAY Probability Of Bankruptcy

BRAINSWAY Stock Price Odds Analysis

What are BRAINSWAY's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of BRAINSWAY jumping above the current price in 90 days from now is about 88.69%. The BRAINSWAY LTD probability density function shows the probability of BRAINSWAY stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon BRAINSWAY has a beta of 0.7999 suggesting as returns on the market go up, BRAINSWAY average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BRAINSWAY LTD will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. BRAINSWAY LTD is significantly underperforming DOW.
 Odds Down 1274.0HorizonTargetOdds Up 1274.0 
11.25%90 days
Based on a normal probability distribution, the odds of BRAINSWAY to move above the current price in 90 days from now is about 88.69 (This BRAINSWAY LTD probability density function shows the probability of BRAINSWAY Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. BRAINSWAY market risk premium is the additional return an investor will receive from holding BRAINSWAY long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BRAINSWAY. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BRAINSWAY's alpha and beta are two of the key measurements used to evaluate BRAINSWAY's performance over the market, the standard measures of volatility play an important role as well.

BRAINSWAY Stock Against Markets

Picking the right benchmark for BRAINSWAY stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BRAINSWAY stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BRAINSWAY is critical whether you are bullish or bearish towards BRAINSWAY LTD at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BRAINSWAY stock to make a market-neutral strategy. Peer analysis of BRAINSWAY could also be used in its relative valuation, which is a method of valuing BRAINSWAY by comparing valuation metrics with similar companies.

BRAINSWAY Corporate Management

Elected by the shareholders, the BRAINSWAY's board of directors comprises two types of representatives: BRAINSWAY inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BRAINSWAY. The board's role is to monitor BRAINSWAY's management team and ensure that shareholders' interests are well served. BRAINSWAY's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BRAINSWAY's outside directors are responsible for providing unbiased perspectives on the board's policies.
Continue to Trending Equities. Note that the BRAINSWAY LTD information on this page should be used as a complementary analysis to other BRAINSWAY's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for BRAINSWAY Stock

When running BRAINSWAY LTD price analysis, check to measure BRAINSWAY's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BRAINSWAY is operating at the current time. Most of BRAINSWAY's value examination focuses on studying past and present price action to predict the probability of BRAINSWAY's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BRAINSWAY's price. Additionally, you may evaluate how the addition of BRAINSWAY to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements